ClinicalTrials.gov
public full text
Public Domain
Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients#405114
- Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery#1095126
- PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced Melanoma#1096250
- Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma#908839
- ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer#1125334
Record · ID 290980
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive